Phase I, Randomized, Placebo-Controlled, Dose-Escalation Study of GB223, a Fully-Humanized Monoclonal Antibody to RANKL, in Healthy Chinese AdultsChen Li,Haiyan Liu, Yixiang Liao,Yu Zhu,Jingyuan Tian,Xuan Wang,Zhiqin Hu,Yaoxuan Zhan,Xianbo Li,Xintong Liang,Jin He,Yongmei Li,Dewei Shang,Qingshan Zheng,Tenghua Wang,Haifeng Song,Yi FangBioDrugs（2023）引用 0|浏览3AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
